Skip to main content
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. logo

ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings

Ticker · 300009 ISIN · CNE100000GY2 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,016 across all filing types
Latest filing 2024-03-27 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300009

About ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.

https://www.ankebio.com

Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.

Recent filings

Filing Released Lang Actions
关于续聘公司2024年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the company's audit firm for the year 2024. It details the audit firm's qualifications, personnel, independence, and audit fees, and mentions that the reappointment will be submitted to the 2023 annual shareholders' meeting for approval. The document does not contain actual financial statements or audit reports but is a formal announcement about the audit engagement. The document length is 3261 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits the category of an Audit Report / Information announcement (AR) rather than a full Annual Report or Audit Report itself, as it focuses on audit firm appointment information. FY 2024
2024-03-27 Chinese
2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as "安徽安科生物工程(集团)股份有限公司2023 年年度报告摘要" which translates to "Anhui Anke Biological Engineering (Group) Co., Ltd. 2023 Annual Report Summary." It contains detailed financial data for the year 2023, including revenue, net profit, earnings per share, and other financial metrics. It also includes extensive business descriptions, product lines, R&D activities, and strategic initiatives. The document references the full annual report and audit opinions, indicating it is a summary of the full annual report. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-03-27 Chinese
关于增加公司经营范围的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Anhui Anke Biotechnology Engineering (Group) Co., Ltd. regarding the increase in the company's business scope, specifically adding 'medical packaging materials manufacturing' to its operations. It includes details of the board meeting where this was approved and the updated business scope before and after the change. There is no financial data, no mention of financial results, no audit information, no voting results, no legal proceedings, no merger or acquisition activity, and no report publication. The document is a formal announcement about a change in the company's business operations approved by the board. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit into more specific categories.
2024-03-27 Chinese
战略及投资委员会工作细则（2024年3月）
Governance Information Classification · 95% confidence The document is titled as the 'Board of Directors Strategic and Investment Committee Work Rules' of a company. It details the establishment, composition, responsibilities, meeting procedures, and operational rules of a board committee. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no announcements of reports, or any other typical financial or regulatory content. The document is a governance-related internal rules document describing the structure and function of a board committee. Therefore, it fits best under Governance Information (CGR). The document length is short and focused on governance rules, not a report or announcement.
2024-03-27 Chinese
关于变更公司董事、监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the company's board and supervisory personnel, specifically the resignation of a supervisory chairman and the nomination of a new non-independent director. It includes details about the individual's qualifications and compliance with legal requirements. There is no financial data, report, or presentation content. The document fits the category of Board/Management Information (MANG) as it announces changes in the company's board and senior management.
2024-03-27 Chinese
公司章程修正案（2024年3月）
Governance Information Classification · 100% confidence The document is titled as an amendment to the company's Articles of Association (公司章程修正案) dated March 2024. It details specific changes to the company's charter, including capital structure, board composition, management roles, shareholder meeting procedures, and other governance-related provisions. The content focuses on internal governance rules, board and management structure, shareholder rights, and procedural changes to the company's constitution. There is no financial data, earnings information, or audit content. The document is a formal governance document revising the company's internal rules and bylaws. Therefore, it fits the category of Governance Information (CGR). The document length is sufficient and contains detailed governance content, not just an announcement or summary, so it is not a Report Publication Announcement or Regulatory Filing.
2024-03-27 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.